on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group, Inc. Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has filed a Form 8.3 disclosing its interests in Mural Oncology plc, as per the requirements of the Irish Takeover Panel. The form was filed on September 3, 2025, detailing Vanguard's position on September 2, 2025.
Vanguard owns and controls 771,411 shares, representing 4.47% of the $0.01 ordinary shares in Mural Oncology plc. The filing indicates no cash-settled or stock-settled derivatives held by Vanguard related to these securities.
Recent transactions related to these securities include the sale of 32 shares at $2.08 each. Vanguard confirms no involvement in any indemnity, option arrangements, or agreements concerning these securities.
No supplemental Form 8 has been attached, and no other parties are involved in additional disclosures according to the document.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news